Powder: -20°C for 3 years | In solvent: -80°C for 1 year
APG-1387 (SM-1387) is an IAP inhibitor that promotes the rapid degradation of cIAP1/2 and XIAP and exerts an anti-tumor effect on nasopharyngeal carcinoma stem cells. Studies have shown that APG-1387 combined with NPC's CDDP and 5-FU enhance chemoresensitivity and promote cell apoptosis in vitro and in vivo.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 1,610.00 | |
10 mg | Inquiry | $ 2,690.00 |
Description | APG-1387 (SM-1387) is an IAP inhibitor that promotes the rapid degradation of cIAP1/2 and XIAP and exerts an anti-tumor effect on nasopharyngeal carcinoma stem cells. Studies have shown that APG-1387 combined with NPC's CDDP and 5-FU enhance chemoresensitivity and promote cell apoptosis in vitro and in vivo. |
Synonyms | SM 1387, SM-1387, SM1387, APG 1387l |
Molecular Weight | 1157.41 |
Formula | C60H72N10O10S2 |
CAS No. | 1570231-89-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
APG-1387 1570231-89-8 SM 1387 APG 1387 SM-1387 APG1387 SM1387 APG 1387l inhibitor inhibit